DRKS00014242
尚未招募
不适用
Prevalence of lysosomal acid lipase deficiency (LAL-D) in patients waitlisted for liver transplantation in Germany by analysis of dried blood specimens and gene sequencing - LAL-D LTW
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- E75.5
- 发起方
- Alexion Pharma Germany GmbH
- 入组人数
- 1000
- 状态
- 尚未招募
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Patient waitlisted for LT (liver transplantation)
- •\- Informed consent form signed by patient or legal representative(s).
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
Unknown
不适用
Assessment of the Prevalence of Lysosomal Acid Lipase Deficiency in Patients Waiting for a Liver Transplant.Patients Waiting for a Liver Transplant.NCT02852304Hospices Civils de Lyon100
Unknown
不适用
Assessement of the Prevalence of Lysosomal Acid Lipase Deficiency in Liver Post-transplant PatientsLiver Post-transplant PatientsNCT02851550Hospices Civils de Lyon100
终止
不适用
A Study to Identify and Characterize LAL-D Patients in High-risk PopulationsLysosomal Acid Lipase DeficiencyNCT02345421Alexion Pharmaceuticals, Inc.640
终止
不适用
Screening for Lysosomal Acid Lipase DeficiencyLysosomal Acid Lipase DeficiencyNCT02926872Alexion Pharmaceuticals, Inc.22
Unknown
不适用
Prevalence of Lysosomal Hydrolase Alpha-glagtosidase Deficiency in Patients With Antiphospholipid Syndrome.Antiphospholipid SyndromeNCT03384485Meir Medical Center100